SF3B1 and myelodysplastic syndrome: Irrespective of the SF3B1 mutation status, MDS-RS-SLD patients showed the best OS within the entire MDS cohort, while in contrast MDS with excess blasts was associated with the shortest OS (Supplementary Fig. S1A).